Rubicon Organics Announces Appointment of Glen Ibbott as CFO

Rhea-AI Summary

Rubicon Organics (OTCQX: ROMJF) appointed Glen Ibbott as Chief Financial Officer and Corporate Secretary, effective after a six-month interim period, announced Nov 13, 2025. Mr. Ibbott has over 25 years of finance leadership in life sciences and cannabis, served as CFO of Aurora Cannabis from 2017–2024, and held senior roles including at QLT where he was involved in a $500 million merger.

The company said his prior six months as interim CFO demonstrated strategic impact while he holds a CPA and MBAs from Cornell and Queen’s. The appointment signals continuity in financial leadership as Rubicon scales premium cannabis operations and expands markets.

Positive

• Interim CFO for six months before permanent appointment
• Executive with 25+ years of finance leadership
• CFO at Aurora Cannabis 2017–2024
• Involved in a $500 million merger at QLT

Negative

• No forward-looking financial guidance or quantified targets provided

VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB) as its Chief Financial Officer and Corporate Secretary.

“Over the past six months, Glen has demonstrated exceptional leadership, deep industry expertise, and a strong alignment with our values. His strategic insight and financial acumen have already made a significant impact as we scale operations and strengthen our position as Canada’s leader in premium cannabis. We are thrilled to welcome Glen on board as a permanent member of our executive team and look forward to his continued contributions as we drive growth and innovation”, said Margaret Brodie, CEO.

Mr. Ibbott commented “I’m thrilled to continue my journey with Rubicon Organics as Chief Financial Officer. Over the past six months, I’ve seen firsthand the strength of our team, the power of our premium brands, and the incredible opportunities ahead as we scale and expand into new markets. Rubicon is uniquely positioned to lead the next chapter of growth in the high-quality, premium cannabis industry, and I’m excited to help unlock that potential and deliver long-term value for our shareholders.”

Glen Ibbott is a seasoned financial executive with over 25 years of leadership experience in publicly-traded life sciences and cannabis companies. He is best known in the industry for his tenure as CFO at Aurora Cannabis from 2017 to 2024, where he played a pivotal role in the company’s rapid growth, international expansion, and delivery of recurring EBITDA and cash flow. Prior to Aurora, Mr. Ibbott held senior finance roles at several prominent healthcare and pharmaceutical companies, including QLT Inc., where he was instrumental in its $500 million merger with Aegerion Pharmaceuticals. He began his career at KPMG and holds the CPA designation in Canada, as well as MBAs from Cornell University and Queen’s University. His strategic acumen and deep industry knowledge make him a valuable asset in guiding companies through complex financial landscapes. Glen has been working as an interim CFO with Rubicon over the past six months.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics is the Canadian leader in certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the company is scaling a house of trusted, high-performing brands including Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.

The Company’s production base is anchored by its Pacifica facility (Delta, BC) and is now complemented by the acquisition and licensing of its Cascadia facility (Hope, BC), which will expand production capacity by over 40% and support future growth in both domestic and export markets. With proprietary genetics, award-winning products, and certifications enabling international distribution, Rubicon is positioned at the forefront of the premium cannabis segment.

As the Canadian market continues to rationalize and global demand for high-quality cannabis increases, Rubicon Organics’ disciplined execution, brand equity, and consumer loyalty set it apart. The Company’s focus on premium quality, innovation, and operational execution has driven consistent revenue growth and positive Adjusted EBITDA.

Rubicon Organics represents a rare combination of category leadership, operational strength, and long-term growth potential.

CONTACT INFORMATION

Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com

The TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws, including, but not limited to, statements regarding the Company’s future growth, operational plans, market expansion, production capacity, financial performance, and strategic initiatives. Forward-looking information is based on management’s current expectations and assumptions, which are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements.

Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, but are not limited to, assumptions regarding the Company’s ability to execute its business strategy, maintain regulatory compliance, achieve production targets, expand into new markets, and realize anticipated benefits from recent appointments and facility expansions. These statements are subject to various risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking information. Such risks and uncertainties include, but are not limited to: changes in general economic, business, and political conditions; regulatory changes; competitive pressures; operational challenges; and other factors described in the Company’s public filings available on SEDAR+ at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on such forward-looking information. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.

All forward-looking information in this press release is made as of the date hereof and is based on the beliefs, estimates, and opinions of management as of the date such statements are made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable law.

FAQ

Who is the new CFO of Rubicon Organics (ROMJF) and when was the appointment announced?

Glen Ibbott was appointed Chief Financial Officer and Corporate Secretary; the appointment was announced Nov 13, 2025.

How long has Glen Ibbott worked with Rubicon Organics before becoming CFO (ROMJF)?

He served as interim CFO with Rubicon for six months prior to the permanent appointment.

What relevant experience does Rubicon’s new CFO Glen Ibbott have for ROMJF investors?

He has over 25 years of finance experience, was CFO at Aurora Cannabis from 2017–2024, and participated in a $500 million merger at QLT.

Does Glen Ibbott hold professional qualifications relevant to his role at Rubicon Organics (ROMJF)?

Yes; he holds the CPA designation in Canada and MBAs from Cornell and Queen’s.

What does the CFO appointment mean for Rubicon Organics’ financial leadership (ROMJF)?

The appointment formalizes continuity in financial leadership after a six-month interim period and indicates management stability while Rubicon scales operations.